Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells

Brain Research

Volumn 722, Issue 1-2, 1996, Pages 232-235

  Burke, William J ^a   Schmitt, Catherine A ^a   Gillespie, Kathleen N ^a   Li, Shu Wen ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

3,4 dihydroxyphenylglycolaldehyde; catecholamine; MAO A metabolite; neurotoxin; PC 12 cell

Indexed keywords

2',3,4 TRIHYDROXYACETOPHENONE; 3,4 DIHYDROXYMANDELIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; 3,4 DIHYDROXYPHENYLGLYCOLALDEHYDE; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; ADRENALIN; METADRENALIN; NORADRENALIN; NORADRENALIN DERIVATIVE; PARGYLINE; UNCLASSIFIED DRUG; VANILMANDELIC ACID;

ADULT; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL;

EID: 0029941785     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00129-1     Document Type: Article

References (24)

1. Arango, V., Ruggiero, D.A., Callaway, J.L., Anwar, M., Mann, J.J. and Reis, D.J., Catecholaminergic neurons in the ventrolateral medulla and nucleus of the solitary tract in the human, J. Comp. Neurol., 273 (1988) 224-240.
2. Blaschko, H., Amine oxidase and amine metabolism, Pharmacol. Rev., 4 (1952) 415-453.
3. Bondareff, W., Mountjoy, C.D. and Roth, M., Loss of neurons of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia, Neurology, 32 (1982) 164-168.
4. Burke, W.J., Davis, J.W., Joh, T.H., Reis, D.A., Horenstein, S. and Bhagat, B.D., The effect of epinephrine on phenylethanolamine N-methyltransferase in cultured explants of adrenal medulla, 103 (1978) 358-367.
5. Burke, W.J., Mattammal, M.B., Marshall, G.L. and Chung, H.D., Detection of 3,4-dihydroxyphenylglycolaldehyde in human brain by high-performance liquid chromatography, Anal. Biochem., 180 (1989) 79-84.
6. Burke, W.J., Chung, H.D., Marshall, G.L., Gillespie, K.N. and Joh, T.H., Evidence for decreased transport of PNMT protein in advanced Alzheimer's disease, J. Am. Geriatr. Soc., 38 (1990) 1275-1282.
7. Burke, W.J., Galvin, N.J., Chung, H.D., Stoff, S.A., Gillespie, K.N., Cataldo, A.M. and Nixon, R.A., Degenerative changes in epinephrine tonic vasomotor neurons in Alzheimer's disease, Brain Res., 661 (1994) 35-42.
8. Burke, W.J., Raghu, G. and Strong, R., Taxol protects against calcium-mediated death of differentiated rat pheochromocytoma cells, Life Sci., 55 (1994) 313-319.
9. Burke, W.J., Wessel, T.C., Joh, T.H., Schmitt, C.A. and Chung, H.D., Defective axonal transport: a mechanism in degeneration of epinephrine neurons in Alzheimer's disease, Neurology, 45 (1995) A307 (Abstract).
10. Burke, W.J., Schmitt, C.A., Li, S.W., Gillespie, K.N., Park, D.H. and Joh, T.H., Measurement of enzyme activity, protein, mRNA and metabolites in small samples, Anal. Biochem., 230 (1995) 345-348.
11. Lassman, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K. and Wisniewski, H., Cell death in Alzheimer's disease evaluated by DNA fragmentation insitu, Acta Neuropathol., 89 (1995) 35-41.
12. Fuller, R.W. and Hemrick-Luecke, S.K., Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase, Res. Commun. Chem. Pathol. Pharmacol., 32 (1981) 207-219.
13. Gai, W.P., Geffen, L.B., Denoroy, L. and Blessing, W.W., Loss of C-1 and C-3 epinephrine-synthesizing neurons in medulla oblongata in Parkinson's disease, Ann. Neurol., 33 (1993) 357-367.
14. Goldstein, M., Pearson, J., Sauter, A., Veta, K., Asano, T., Engel, J., Passeltiner, P., Hokfelt, T. and Fuxe, K., Distribution and characterization of PNMT and epinephrine in the CNS. In K. Fuxe, M. Goldstein, B. Hökfelt and T. Hökfelt (Eds.), Central Adrenaline Neurons: Basic Aspects and Their Role in Cardiovascular Functions, Reed Elsevier, Oxford, 1980, pp. 49-55.
15. Granata, A.R., Ruggiero, D.A., Park, D.H., Joh, T.H. and Reis, D.J., Brain stem area with C-1 epinephrine neurons mediates baroreflex vasodepressor responses, Am. J. Physiol., 248 (1985) 547-567.
16. Klockers, A.J. and Say, G., Multiple Comparisons, Sage University Paper Series on Quantitative Applications in the Social Sciences (no. 07-061), Sage Publications, Beverly Hills, CA, 1986.
17. Li, S.W., Elliott, W.H. and Burke, W.J., Synthesis of a biochemically important aldehyde, 3,4-dihydroxyphenylglycolaldehyde, Bioorg. Chem., 22 (1994) 337-342.
18. Markey, J.P., Johanessen, J.N., Chiveh, C.C., Burns, S.S. and Herkenham, M.A., Intraneuronal generation of pyridinium metabolite may cause drug-induced Parkinsonism, Nature, 311 (1984) 464-467.
19. 3H-thymidine-labelled cells prior to autoradiography, Stain Technol., 12 (1967) 143-145.
20. Sharman, P.F., Catabolism of catecholamines, Br. Med. Bull., 29 (1973) 110-115.
21. Siegel, G.J., Albers, R.W., Agranoff, B.W. and Katzman, R., Basic Neurochemistry, Little-Brown and Company, Boston, 1981, 857 pp.
22. Thompson, C.B., Apoptosis in the pathogenesis and treatment of disease, 267 (1994) 1456-1462.
23. Walkinshaw, G. and Water, C.M., Neurotoxin-induced cell death in neuronal PC-12 cells is mediated by induction of apoptosis, Neuroscience, 631 (1994) 975-987.
24. Westlund, K.N., Denney, R.M., Kochersperger, L.M., Rose, R.M. and Abell, C.W., Distinct monoamine oxidase A and B populations in primate brain, Science, 230 (1985) 181-183.